These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16421174)

  • 1. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina.
    Minoretti P; Falcone C; Calcagnino M; Emanuele E; Buzzi MP; Coen E; Geroldi D
    Eur Heart J; 2006 Apr; 27(7):802-7. PubMed ID: 16421174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study.
    Georgiadou P; Iliodromitis EK; Kolokathis F; Varounis C; Gizas V; Mavroidis M; Capetanaki Y; Boudoulas H; Kremastinos DT
    Eur J Clin Invest; 2010 Apr; 40(4):288-93. PubMed ID: 20192976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris.
    Avanzas P; Arroyo-Espliguero R; Quiles J; Roy D; Kaski JC
    Eur Heart J; 2005 Mar; 26(5):457-63. PubMed ID: 15684278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
    Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
    Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina.
    Elesber AA; Conover CA; Denktas AE; Lennon RJ; Holmes DR; Overgaard MT; Christiansen M; Oxvig C; Lerman LO; Lerman A
    Eur Heart J; 2006 Jul; 27(14):1678-84. PubMed ID: 16717071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris.
    Cosin-Sales J; Kaski JC; Christiansen M; Kaminski P; Oxvig C; Overgaard MT; Cole D; Holt DW
    Eur Heart J; 2005 Oct; 26(20):2093-8. PubMed ID: 16055491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.
    Schnabel R; Messow CM; Lubos E; Espinola-Klein C; Rupprecht HJ; Bickel C; Sinning C; Tzikas S; Keller T; Genth-Zotz S; Lackner KJ; Münzel TF; Blankenberg S
    Eur Heart J; 2008 Mar; 29(5):649-57. PubMed ID: 18263867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    Sinning JM; Bickel C; Messow CM; Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Lackner KJ; Tiret L; Münzel T; Blankenberg S;
    Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
    Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Bickel C; Lackner KJ; Cambien F; Tiret L; Münzel T; Blankenberg S
    J Am Coll Cardiol; 2006 Feb; 47(3):552-8. PubMed ID: 16458135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma.
    Hotte SJ; Winquist EW; Stitt L; Wilson SM; Chambers AF
    Cancer; 2002 Aug; 95(3):506-12. PubMed ID: 12209742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization.
    Susen S; Sautière K; Mouquet F; Cuilleret F; Chmaït A; McFadden EP; Hennache B; Richard F; de Groote P; Lablanche JM; Dallongeville J; Bauters C; Jude B; Van Belle E
    Eur Heart J; 2005 Nov; 26(22):2387-95. PubMed ID: 16105849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
    Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
    Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
    Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA
    Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia as independent predictor of major events in elderly patients with chronic angina.
    Muzzarelli S; Pfisterer M;
    Am Heart J; 2006 Nov; 152(5):991-6. PubMed ID: 17070178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease.
    Falcone C; Minoretti P; D'Angelo A; Buzzi MP; Coen E; Emanuele E; Aldeghi A; Olivieri V; Geroldi D
    Eur J Clin Invest; 2006 Apr; 36(4):211-7. PubMed ID: 16620281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial.
    Abdalrhim AD; Marroush TS; Austin EE; Gersh BJ; Solak N; Rizvi SA; Bailey KR; Kullo IJ
    PLoS One; 2016; 11(6):e0156965. PubMed ID: 27284698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.